XML 43 R27.htm IDEA: XBRL DOCUMENT
v3.25.2

STOCKHOLDERS EQUITY (Details Narrative) - USD ($) | 1 Months Ended | 3 Months Ended | 9 Months Ended |
--- | --- | --- | --- | ---
May 31, 2025 | Mar. 31, 2025 | Dec. 31, 2024 | Oct. 31, 2024 | Apr. 19, 2024 | Feb. 29, 2024 | Nov. 30, 2023 | Jun. 30, 2025 | Jun. 30, 2024 | Jun. 30, 2025 | Jun. 30, 2024 | Sep. 30, 2024
Consulting fees inclued prepaid expenses |  |  |  |  |  |  |  | $ 304,133 |  | $ 304,133 |  | $ 294,097
Total share-based compensation expense |  |  |  |  |  |  |  |  |  | $ 1,470,491 | $ 3,544,569 |
Stock issuance cost | $ 500,000 | $ 500,000 | $ 600,000 |  |  | $ 700,000 | $ 500,000 |  |  |  |  |
Sale of Common Stock | 2,000,000 | 133,750 | 251,750 |  |  | 129,167 | 83,000 |  |  |  |  |
Stock options vested |  |  |  |  | 7,811 |  |  |  |  |  |  |
Common stock shares issued |  |  |  |  |  |  |  | 5,321,341 |  | 5,321,341 |  | 2,126,682
Public offering price | $ 2.50 | $ 4.80 | $ 9.30 |  |  | $ 60.00 | $ 60.00 |  |  |  |  |
Proceeds from issuance of common stock | $ 4,500,000 | $ 2,100,000 | $ 4,400,000 |  |  | $ 7,000,000.0 | $ 4,500,000 |  |  | $ 12,560,300 | $ 12,730,000 |
Number of pre-funded warrants exercised |  |  |  |  |  |  |  | $ 285,917 |  | $ 285,917 |  |
Compensation cost |  |  |  |  | $ 260,000 |  |  |  | $ 101,000,000,000 |  |  |
Changes in Equity Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |
Number of pre-funded warrants issued |  |  |  |  |  |  |  |  |  | 399,583 |  |
Number of pre-funded warrants exercised |  |  |  |  |  |  |  |  |  | 733,834 |  |
Public offering price |  |  |  |  |  |  |  | 4.80 |  | $ 4.80 |  |
Changes in Equity Warrants One [Member] |  |  |  |  |  |  |  |  |  |  |  |
Number of pre-funded warrants issued |  |  |  |  |  |  |  |  |  | 285,917 |  |
Public offering price |  |  |  |  |  |  |  | $ 9.30 |  | $ 9.30 |  |
Consulting Agreements [Member] |  |  |  |  |  |  |  |  |  |  |  |
Weighted average grant date fair value |  |  |  |  |  |  |  |  |  | 26.13 | $ 55.29 |
Exercise price |  |  |  |  |  |  |  |  |  | $ 21.00 |  |
Common stock issued for service, shares |  |  |  |  |  |  |  |  |  | 6,821 | 10,726 |
Number of options granted |  |  |  |  |  |  |  |  |  | 16,667 |  |
Total share-based compensation expense |  |  |  |  |  |  |  | $ 81,000 | $ 231,000 | $ 587,000 | $ 601,000 |
Consulting Agreements Other [Member] |  |  |  |  |  |  |  |  |  |  |  |
Consulting fees inclued prepaid expenses |  |  |  |  |  |  |  | $ 48,000 |  | $ 48,000 |  | $ 52,000
Ergomed [Member] |  |  |  |  |  |  |  |  |  |  |  |
Stock issuance cost |  |  |  | $ 61,000 |  |  |  |  |  |  |  |
Sale of Common Stock |  |  |  |  |  |  |  |  |  | 33,334 |  |
Common stock shares issued |  |  |  | 33,334 |  |  |  |  |  |  |  |
Proceeds from issuance of common stock |  |  |  |  |  |  |  |  |  | $ 350,885 |  |
Restricted Stock [Member] | Consultants [Member] |  |  |  |  |  |  |  |  |  |  |  |
Weighted average grant date fair value |  |  |  |  |  |  |  |  |  |  | $ 39.86 |
Common stock issued for service, shares |  |  |  |  |  |  |  |  |  | 0 | 2,348 |
Pre-Funded [Member] |  |  |  |  |  |  |  |  |  |  |  |
Common stock shares issued | 399,584 |  | 285,917 |  |  |  |  |  |  |  |  |
Public offering price | $ 4.79 |  | $ 9.29 |  |  |  |  |  |  |  |  |

X
- References No definition available. + Details
Name: | cvm_CompensationCost
Namespace Prefix: | cvm_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | cvm_ShareBasedPaymentArrangementNumberOfInstrumentsExercised
Namespace Prefix: | cvm_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | cvm_ShareBasedPaymentArrangementNumberOfInstrumentsGranted
Namespace Prefix: | cvm_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | cvm_ShareBasedPaymentArrangementNumberOfInstrumentsGranted20
Namespace Prefix: | cvm_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | cvm_StockIssuanceCost
Namespace Prefix: | cvm_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | cvm_StockWarrantsExercised
Namespace Prefix: | cvm_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- References No definition available. + Details
Name: | cvm_hareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
Namespace Prefix: | cvm_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_CommonStockSharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of excess stock shares of an entity that have been sold or granted to shareholders. + References No definition available. + Details
Name: | us-gaap_ExcessStockSharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(7)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 340 -SubTopic 10 -Name Accounting Standards Codification -Section 05 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482955/340-10-05-5 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 340 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1 + Details
Name: | us-gaap_PrepaidExpenseCurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The cash inflow from the additional capital contribution to the entity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 14 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14 + Details
Name: | us-gaap_ProceedsFromIssuanceOfCommonStock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of noncash expense for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28 + Details
Name: | us-gaap_ShareBasedCompensation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of options vested. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-4 + Details
Name: | us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. + References No definition available. + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesIssuedForServices
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Per share increase in exercise price of option. Excludes change due to standard antidilution provision and option granted under share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_StockOptionExercisePriceIncrease
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_TradingActivityByTypeAxis=cvm_ChangesInEquityWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TradingActivityByTypeAxis=cvm_ChangesInEquityWarrantsOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PlanNameAxis=cvm_ConsultingAgreementsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PlanNameAxis=cvm_ConsultingAgreementsOtherMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PlanNameAxis=cvm_ErgomedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cvm_RestrictedStocksMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cvm_ConsultantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=cvm_PreFundedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |